A new electroanatomical cardiac mapping system becomes available that has significant advantages over current systems in the EP laboratory and is cost neutral. A novel ICE system is released after FDA approval and is available at the same price as other systems on the market. How difficult will it be to get these new technologies into the hospital, so that patients can potentially benefit?
Michael Megaly, MD, MS and colleagues discuss how subclinical new-onset AF/AFL (NOAF) is common after transcatheter aortic valve replacement (TAVR), usually occurs months after hospital discharge, and is associated with lack of anticoagulation therapy and increased risk of stroke. Prolonged surveillance of subclinical NOAF may be warranted after TAVR.
The ExPlore: Innovations in Electrophysiology for the Allied Professional symposium is now in its third year, and continues to grow. This year’s event will take place November 2nd at the Harris Conference Center in Charlotte, North Carolina.
Pugazhendhi Vijayaraman, MD, FHRS and colleagues from Geisinger Heart Institute describe the feasibility of pacing beyond the site of block in the proximal left bundle in a patient with left bundle branch block and complete infranodal AV block following TAVR. Left bundle branch area pacing was associated with excellent pacing parameters.
Joshua D. Lovelock, MD and Richard L. Harvey, MD from The CardioVascular Group and Gwinnett Medical Center report the case of a patient with longstanding persistent atrial fibrillation treated with Convergent (hybrid) atrial fibrillation ablation.
Robert Schweikert, MD, and John Flavelle, BSN, RN describe the recent EP lab renovation at Cleveland Clinic Akron General. Today, the space is a modern and efficient lab that maximizes workflow, patient safety, and comfort.